Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy (Q45273813)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy |
scientific article |
Statements
1 reference
Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy (English)
1 reference
Bonaventura Clotet
1 reference
Daniel Fuster
1 reference
Jaime A Huertas
1 reference
Guadalupe Gómez
1 reference
Ricard Solà
1 reference
Juan González García
1 reference
Josep Vilaró
1 reference
Enric Pedrol
1 reference
Lluís Force
1 reference
Jordi Tor
1 reference
Guillem Sirera
1 reference
Sebastiá Videla
1 reference
Ramon Planas
1 reference
Cristina Tural
1 reference
PEG-TOX Research Group
1 reference
1 January 2005
1 reference
1 reference